JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M605437200 on July 10, 2006

J. Biol. Chem., Vol. 281, Issue 36, 26340-26349, September 8, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/36/26340    most recent
M605437200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Policha, A.
Right arrow Articles by Ferguson, S. S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Policha, A.
Right arrow Articles by Ferguson, S. S. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Role of Angiotensin II Type 1A Receptor Phosphorylation, Phospholipase D, and Extracellular Calcium in Isoform-specific Protein Kinase C Membrane Translocation Responses*

Aleksandra Policha{ddagger}§1, Noriko Daneshtalab{ddagger}, Lina Chen, Lianne B. Dale{ddagger}, Christophe Altier2, Houman Khosravani, Walter G. Thomas||, Gerald W. Zamponi3, and Stephen S. G. Ferguson, Holds a Canada Research Chair in molecular neurobiology and is a Career Investigator of the Heart and Stroke Foundation of Ontario{ddagger}§4

From the {ddagger}Cell Biology Research Group, Robarts Research Institute, §Department of Physiology and Pharmacology, The University of Western Ontario, 100 Perth Drive, London, Ontario N6A 5K8, Canada, Department of Physiology, Hotchkiss Brain Institute, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta T2N 4N1, Canada, and ||Baker Heart Research Institute, St. Kilda Road Central, Melbourne 8008, Australia

The angiotensin II type 1A receptor (AT1AR) plays an important role in cardiovascular function and as such represents a primary target for therapeutic intervention. The AT1AR is coupled via Gq to the activation of phospholipase C, the hydrolysis of phosphoinositides, release of calcium from intracellular stores, and the activation of protein kinase C (PKC). We show here that PKCbetaI and PKCbetaII exhibit different membrane translocation patterns in response to AT1AR agonist activation. Whereas PKCbetaII translocation to the membrane is transient, PKCbetaI displays additional translocation responses: persistent membrane localization and oscillations between the membrane and cytosol following agonist removal. The initial translocation of PKCbetaI requires the release of calcium from intracellular stores and the activation of phospholipase C, but persistent membrane localization is dependent upon extracellular calcium influx. The mutation of any of the three PKC phosphorylation consensus sites (Ser-331, Ser-338, and Ser-348) localized within the AT1AR C-tail significantly increases the probability that persistent increases in diacylglycerol levels and PKCbetaI translocation responses will be observed. The persistent increase in AT1AR-mediated diacylglycerol formation is mediated by the activation of phospholipase D. Although the persistent PKCbetaI membrane translocation response is absolutely dependent upon the PKC activity-dependent recruitment of an extracellular calcium current, it does not require the activation of phospholipase D. Taken together, we show that the patterning of AT1AR second messenger response patterns is regulated by heterologous desensitization and PKC isoform substrate specificity.


Received for publication, June 6, 2006 , and in revised form, July 7, 2006.

* This work was supported in part by Heart and Stroke Foundation of Ontario (HSFO) Grant T-5933 (to S. S. G. F.), HSFO Program Grant PRG-5967, and a Canadian Institutes of Health Research grant (to G. W. Z.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Recipient of an Ontario graduate studentship.

2 Recipient of fellowships from the Alberta Heritage Foundation for Medical Research (AHFMR) and the Heart and Stroke Foundation of Canada.

3 An AHFMR Senior Scholar. Holds a Canada Research Chair in molecular neurobiology.

4 To whom correspondence should be addressed: Robarts Research Inst., 100 Perth Dr., P. O. Box 5015, London, Ontario N6A 5K8, Canada. Tel.: 519-663-3825; Fax: 519-663-3314; E-mail: ferguson{at}robarts.ca.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.